14. Supplemental Cash Flow Information

9 Months Ended

Sep. 30, 2015

Supplemental Cash Flow Elements [Abstract]

14. Supplemental Cash Flow Information

Note 14. Supplemental Cash Flow Information

		Nine Months Ended
		September 30,
		2015		2014
Supplemental disclosures of Cash Flow Information:
Cash paid for income taxes, net	$	140	$	615
Cash paid for interest		27,736		4,609
Supplemental disclosures of Non-cash Investing and Financing Activities:
Conversion of 8.00% Convertible notes		60,172		-
Issuance of 1,682,086 shares to Zogenix for Zohydro acquisition		11,926		-
Acquisition of TREXIMET® - warrants issued to Pozen		-		2,359
Acquisition of license - contract payable		-		1,950